您的位置：山东大学 -> 科技期刊社 -> 《山东大学学报（医学版）》

山东大学学报（医学版） ›› 2017, Vol. 55 ›› Issue (1): 69-74.doi: 10.6040/j.issn.1671-7554.0.2016.1313

• 临床医学 • 上一篇    下一篇

microRNA-183在PCOS胰岛素抵抗中的表达及其临床意义

李婧博,刘洪彬,贾月月,王泽,孙梅,石玉华   

  1. 山东大学附属生殖医院 国家辅助生殖与优生工程技术研究中心 生殖内分泌教育部重点实验室(山东大学)山东省生殖医学重点实验室, 山东 济南 250001
  • 收稿日期:2016-10-14 出版日期:2017-01-10 发布日期:2017-01-10
  • 通讯作者: 石玉华. E-mail:shiyuhua2003@126.com E-mail:shiyuhua2003@126.com
  • 基金资助:
    国家科技支撑计划(2012BAI32B04);国家自然科学基金面上项目(81471428,81200423);山东省科技发展计划(2014GSF118070);山东省人口和计划生育委员会科技计划(2013-03);山东大学青年学者未来计划(第二批,2016WLJH50);山东大学附属生殖医院自主创新项目(20141102,20141103)

Expression and clinical significance of microRNA-183 in polycystic ovary syndrome with insulin resistance

LI Jingbo, LIU Hongbin, JIA Yueyue, WANG Ze, SUN Mei, SHI Yuhua   

  1. Center for Reproductive Medicine, Shandong University;
    National Research Center for Assisted Reproductive Technology and Reproductive Genetics;
    Key Laboratory for Reproductive Endocrinology(Shandong University), Ministry of Education;
    Shandong Provincial Key Laboratory of Reproductive Medicine, Jinan 250001, Shandong, China
  • Received:2016-10-14 Online:2017-01-10 Published:2017-01-10

PDF (PC)

387

摘要： 目的 检测多囊卵巢综合征(PCOS)胰岛素抵抗患者卵巢颗粒细胞中microRNA-183(miR-183)的表达,并评价其临床意义。 方法 采用实时荧光定量逆转录聚合酶链反应(qRT-PCR)检测120例PCOS患者［其中 78例PCOS胰岛素抵抗患者(PCOS胰岛素抵抗组)和42例PCOS非胰岛素抵抗患者(PCOS非胰岛素抵抗组)及72例正常对照者(正常对照组)］颗粒细胞中miR-183的表达,并对miR-183表达和胰岛素抵抗指数(HOMA-IR)进行关联分析,同时对组间临床资料进行回顾性分析。采用受试者工作特征(ROC)曲线评价miR-183的诊断效能。 结果 miR-183在PCOS胰岛素抵抗组颗粒细胞中的表达高于正常对照组(P<0.001)及非胰岛素抵抗组(P=0.034),PCOS胰岛素抵抗组miR-183的表达与HOMA-IR呈正相关(r=0.476, P=0.003),ROC曲线提示miR-183联合体质量指数(BMI)作为PCOS胰岛素抵抗的评价指标,其诊断效能较高(AUC: 0.820, 95%CI: 0.750~0.889, P<0.001)。 结论 miR-183在PCOS胰岛素抵抗患者颗粒细胞中高表达,并与HOMA-IR相关,其可能通过卵泡局部微环境参与调控PCOS胰岛素抵抗的致病过程。

关键词: 多囊卵巢综合征, 胰岛素抵抗, miR-183, 颗粒细胞

Abstract: Objective To explore the expression of microRNA-183(miR-183)in the ovarian granulosa cells of polycystic ovary syndrome(PCOS)patients with insulin resistance(IR), and to evaluate its clinical significance. Methods A total of 120 PCOS patients including 78 with insulin resistance and 42 without, and 72 healthy controls were enrolled. The miR-183 expression was examined by real-time quantitative reverse transcription PCR(qRT-PCR). The correlation between miR-183 and homeostasis model assessment-insulin resistance(HOMA-IR)was analyzed. The area under the receiver operating characteristic(ROC)curve(AUC)was calculated to evaluate the predictive power of miR-183 for PCOS insulin resistance. Results PCOS patients with insulin resistance had higher miR-183 expression than the control group(P<0.001)and PCOS without insulin resistance group(P=0.034). There was positive correlation 山 东 大 学 学 报 (医 学 版)55卷1期 -李婧博,等.microRNA-183在PCOS胰岛素抵抗中的表达及其临床意义 \=-between HOMA-IR and miR-183 expression in PCOS with insulin resistance group(r=0.476, P=0.003). The ROC analysis suggested that combination of miR-183 and body mass index(BMI)(AUC: 0.820, 95%CI: 0.750-0.889, P<0.001)might be an effective indicator. Conclusion The high expression of miR-183 is correlated to insulin resistance of PCOS and HOMA-IR, and may be involved in the pathogenesis of PCOS insulin resistance through follicular microenvironment.

Key words: MicroRNA-183, Insulin resistance, Granulosa cell, Polycystic ovary syndrome

中图分类号: 

  • R711.75
[1] Pertynska-Marczewska M, Diamanti-Kandarakis E, Zhang J, et al. Advanced glycation end products: a link between metabolic and endothelial dysfunction in polycystic ovary syndrome?[J]. Metabolism, 2015, 64(11): 1564-1573.
[2] Polak K, Czyzyk A, Simoncini T, et al. New markers of insulin resistance in polycystic ovary syndrome[J]. J Endocrinol Invest, 2016, 10. 1007/s40618-016-0523-8
[3] Ciaraldi TP, Aroda V, Mudaliar S, et al. Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance[J]. J Clin Endocrinol Metab, 2009, 94(1): 157-163.
[4] 李晏丽, 宁光. microRNA与胰岛素抵抗[J]. 国际内分泌代谢杂志, 2014, 34(3): 188-190. LI Yanli, NING Guang. Relationship between microRNA and insulin resistance[J]. International Journal of Endocrinology and Metabolism, 2014, 34(3): 188-190.
[5] Gebremedhn S, Salilew-Wondim D, Hoelker M, et al. MicroRNA-183~96~182 cluster regulate bovine granulosa cell proliferation and cell cycle transition by coordinately targeting FOXO1[J]. Biol Reprod, 2016, 94(6): 127.
[6] Motino O, Frances DE, Mayoral R, et al. Regulation of microRNA 183 by cyclooxygenase 2 in liver is DEAD-Box helicase p68(DDX5)dependent: role in insulin signaling[J]. Mol Cell Biol, 2015, 35(14): 2554-2567.
[7] Kaur S, Archer KJ, Devi MG, et al. Differential gene expression in granulosa cells from polycystic ovary syndrome patients with and without insulin resistance: identification of susceptibility gene sets through network analysis[J]. J Clin Endocrinol Metab, 2012, 97(10): E2016-2021.
[8] Rotterdam ESHRE/AS RM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome[J]. Fertil Steril, 2004, 81(1): 19-25.
[9] Matsubara H, Ikuta K, Ozaki Y, et al. Gonadotropins and cytokines affect luteal function through control of apoptosis in human luteinized granulosa cells[J]. J Clin Endocrinol Metab, 2000, 85(4): 1620-1626.
[10] Ovalle F, Azziz R. Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus[J]. Fertil Steril, 2002, 77(6): 1095-1105.
[11] Shi Y, Cui Y, Sun X, et al. Hypertension in women with polycystic ovary syndrome: prevalence and associated cardiovascular risk factors[J]. Eur J Obstet Gynecol Reprod Biol, 2014, 173: 66-70.
[12] Orio F, Vuolo L, Palomba S, et al. Metabolic and cardiovascular consequences of polycystic ovary syndrome[J]. Minerva Ginecol, 2008, 60(1): 39-51.
[13] Xu X, Zhao H, Shi Y, et al. Family association study between INSR gene polymorphisms and PCOS in Han Chinese[J]. Reprod Biol Endocrinol, 2011, 9: 76.
[14] 张文娟, 吴兴国, 丁明德, 等. 脂联素基因多态性与多囊卵巢综合征发病关系的病例对照研究[J]. 中华妇产科杂志, 2015, 50(11): 825-829. ZHANG Wenjuan, WU Xingguo, DING Mingde, et al. Case-control based study between polymorphisms in the adiponectin gene and polycystic ovary syndrome[J]. Chinese Journal of Obstetrics and Gynecology, 2015, 50(11): 825-829.
[15] Hackbart KS, Cunha PM, Meyer RK, et al. Effect of glucocorticoid-induced insulin resistance on follicle development and ovulation[J]. Biol Reprod, 2013, 88(6): 153.
[16] Turner N, Robker RL. Developmental programming of obesity and insulin resistance: does mitochondrial dysfunction in oocytes play a role?[J]. Mol Hum Reprod, 2015, 21(1): 23-30.
[17] Flynt AS, Lai EC. Biological principles of microRNA-mediated regulation: shared themes amid diversity[J]. Nat Rev Genet, 2008, 9(11): 831-842.
[18] Imbar T, Eisenberg I. Regulatory role of microRNAs in ovarian function[J]. Fertil Steril, 2014, 101(6): 1524-1530.
[19] Pierce ML, Weston MD, Fritzsch B, et al. MicroRNA-183 family conservation and ciliated neurosensory organ expression[J]. Evol Dev, 2008, 10(1): 106-113.
[20] Chen H, Zhang L, Zhang L, et al. MicroRNA-183 correlates cancer prognosis, regulates cancer proliferation and bufalin sensitivity in epithelial ovarian caner[J]. Am J Transl Res, 2016, 8(4): 1748-1755.
[21] Baran-Gale J, Fannin EE, Kurtz CL, et al. Beta cell 5'-shifted isomiRs are candidate regulatory hubs in type 2 diabetes[J]. PLoS One, 2013, 8(9): e73240.
[22] Jeon TI, Esquejo RM, Roqueta-Rivera M, et al. An SREBP-responsive microRNA operon contributes to a regulatory loop for intracellular lipid homeostasis[J]. Cell Metab, 2013, 18(1): 51-61.
[23] Xu J, Wong C. A computational screen for mouse signaling pathways targeted by microRNA clusters[J]. RNA, 2008, 14(7): 1276-1283.
[24] Ding L, Gao F, Zhang M, et al. Higher PDCD4 expression is associated with obesity, insulin resistance, lipid metabolism disorders, and granulosa cell apoptosis in polycystic ovary syndrome[J]. Fertil Steril, 2016, 105(5): 1330-1337
[25] Makker A, Goel MM, Mahdi AA. PI3K/PTEN/Akt and TSC/mTOR signaling pathways, ovarian dysfunction, and infertility: an update[J]. J Mol Endocrinol, 2014, 53(3): R103-118.
[26] Hannenhalli S, Kaestner KH. The evolution of Fox genes and their role in development and disease[J]. Nat Rev Genet, 2009, 10(4): 233-240.
[1] 张媛 李英敏 冯月秋 常彩云 潘华伟 王束玫. 血清脂联素水平与肥胖、胰岛素抵抗的关系探讨[J]. 山东大学学报(医学版), 2209, 47(6): 124-.
[2] 万文静,高姗姗. 低分子肝素在生殖领域的应用[J]. 山东大学学报 (医学版), 2025, 63(6): 117-124.
[3] 刘淋,王晓楠,杨雅溪,王江腾,李旭,周新丽,管庆波,张栩. 甘油三酯-葡萄糖指数与颅内动脉粥样硬化性狭窄的相关性[J]. 山东大学学报 (医学版), 2024, 62(8): 93-100.
[4] 许沛晨,李晓博,庄向华,娄能俊,吕丽,周玲雁,牟亚朋,宋玉文,陈诗鸿. 儿童Alstrom综合征2例并文献复习[J]. 山东大学学报 (医学版), 2024, 62(3): 107-111.
[5] 赵元元,路军涛,吴小华. 人脐带间充质干细胞外泌体miR-100对多囊卵巢综合征患者颗粒细胞炎症的影响[J]. 山东大学学报 (医学版), 2023, 61(5): 51-58.
[6] 虎娜,孙苗,邢莎莎,许丹霞,海小明,马玲,杨丽,勉昱琛,何瑞,陈冬梅,马会明. 月见草油抵抗多囊卵巢综合征大鼠卵巢氧化应激[J]. 山东大学学报 (医学版), 2022, 60(5): 22-30.
[7] 宋甜,付琳琳,王秋敏,杨晓,王莹,边月红,石玉华. 脂肪酸转运蛋白1在多囊卵巢综合征患者颗粒细胞中的表达[J]. 山东大学学报 (医学版), 2022, 60(2): 22-26.
[8] 赵美茹,朱迪,刘淋,管庆波,张栩. 简易胰岛素抵抗指标与698例2型糖尿病患者发生高尿酸血症风险的关联[J]. 山东大学学报 (医学版), 2022, 60(12): 44-51.
[9] 牛群,石婧婧,符江. WNT5A基因对卵巢颗粒细胞胰岛素反应性和胰岛素抵抗的调控作用[J]. 山东大学学报 (医学版), 2021, 59(6): 57-63.
[10] 韩笑,李雷,刘聪聪. 睾酮对于多囊卵巢综合征易感基因Tox3表达的影响[J]. 山东大学学报 (医学版), 2021, 59(4): 42-47.
[11] 宫小舒,吴日超,李秀芳,潘烨,王泽,石玉华. 603例多囊卵巢综合征患者不同促排卵内膜准备方案对冻胚移植结局的影响[J]. 山东大学学报 (医学版), 2021, 59(3): 48-54.
[12] 哈灵侠,殷婷,吴阳阳,黎维霞,杜玉冬. 多囊卵巢综合征患者中胰岛素抵抗与子宫内膜局部炎症因子及葡萄糖转运蛋白-4表达的相关性[J]. 山东大学学报 (医学版), 2021, 59(11): 41-47.
[13] 丁祥云,于清梅,张文芳,庄园,郝晶. 胰岛素样生长因子II在84例多囊卵巢综合征患者颗粒细胞中的表达和促排卵结局的相关性[J]. 山东大学学报 (医学版), 2020, 1(7): 60-66.
[14] 徐红照,郝宗山, 沈德嫱,李朝苹,陈立勇. 核糖体蛋白S6激酶2沉默在乙醇诱导的心肌胰岛素抵抗中的作用[J]. 山东大学学报 (医学版), 2020, 58(4): 84-89.
[15] 宋海霞,袁彩霞,范玲玲. 体质量指数对夫精人工授精妊娠结局的影响[J]. 山东大学学报 (医学版), 2020, 58(1): 49-53.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
版权所有 © 2018 《山东大学学报(医学版)》编辑部　
地址:山东大学科技期刊社（济南市历城区山大南路27号山东大学中心校区明德楼B座721室） 电话: 0531-88366918 E-mail: xbyxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发